The purpose of the study was to explore the pathogenic mechanisms underlying generalized epilepsy and febrile seizures plus (GEFS+) in a family with a novel γ2 subunit gene (GABRG2) frameshift mutation. Four affected and one unaffected individuals carried a c.1329delC GABRG2 mutation resulting in a subunit [γ2S(S443delC)] with a modified and elongated carboxy-terminus that is different from that of the wildtype γ2S subunit. We expressed the wildtype γ2S subunit and the predicted mutant γ2S(S443delC) subunit cDNAs in HEK293T cells and performed immunoblotting, flow cytometry and electrophysiology studies. The mutant subunit was translated as a stable protein that was larger than the wildtype γ2S subunit and was retained in the ER and not expressed on the cell surface membrane, suggesting GABRG2 haploinsufficiency. Peak GABA-evoked currents recorded from cells cotransfected with wildtype α1 and β2 subunits and mutant γ2S subunits were significantly decreased and were comparable to α1β2 receptor currents. S443delC is the first GABR epilepsy mutation predicted to abolish the natural stop codon and produce a stop codon in the 3′ UTR that leads to translation of an extended peptide. The GEFS+ phenotype observed in this family is likely caused by γ2S subunit loss-of-function and possibly to dominant-negative suppression of α1β2γ2 receptors. Many GABRG2 truncation mutations result in GEFS+, but the spectrum of phenotypic severity is wider, ranging from asymptomatic individuals to the Dravet syndrome. Mechanisms influencing the severity of the phenotype are therefore complex and difficult to correlate with its demonstrable functional effects.
Introduction
Mutations in GABA A receptor subunit genes have been associated with generalized epilepsy syndromes and with the genetic epilepsy with febrile seizures plus (GEFS+) spectrum, including Dravet syndrome, in rare families and in sporadic cases with de novo mutations (Macdonald et al., 2010) . Epilepsy-associated mutations in GABRG2 include three missense mutations in coding sequences (Audenaert et al., 2006; Baulac et al., 2001; Wallace et al., 2001) , three nonsense mutations in coding sequences (Harkin et al., 2002; Hirose, 2006; Sun et al., 2008) , and one mutation in an intron splice donor site (Kananura et al., 2002) that was shown to cause protein truncation (Tian and Macdonald, 2012) . Missense mutations impaired GABA A receptor membrane trafficking (Eugene et al., 2007; Frugier et al., 2007; Kang and Macdonald, 2004; Sancar and Czajkowski, 2004b) , decreased receptor currents (Bianchi et al., 2002; Eugene et al., 2007) , or affected γ2 subunit biogenesis (Audenaert et al., 2006) . Phenotypes associated with missense mutations are relatively mild and include familial childhood absence epilepsy and febrile seizures (Wallace et al., 2001) , GEFS+ without Dravet syndrome (Baulac et al., 2001 ) and febrile seizures (Audenaert et al., 2006) . Nonsense mutations in coding sequences result in a combination of degradation of unstable subunit mRNA and production of unstable truncated subunits that produce dominant-negative suppression of the biogenesis of wild type subunits (Kang et al., 2009a (Kang et al., , 2009b and cause considerable loss of inhibition, consistent with the more severe phenotypes (Kang et al., 2009a) . Neurobiology of Disease 50 (2013) 135-141 
